// SUPPLIER · WHARTON'S JELLY · MSC EXOSOME MATERIAL
B&H Bio supplies umbilical-cord-derived MSC exosome material to qualified professionals. Every batch ships with an independent Eurofins Certificate of Analysis, a specification sheet, and full batch-level traceability. No claims, no theater — just documented material.
Regulatory notice: No exosome product is FDA-approved for therapeutic use in humans. Material is supplied for research, professional, and investigational use only. Practices rely on their own regulatory counsel.
// PRODUCT LINES
Amniotic fluid-derived MSC exosome material. Unadulterated — no mixing, no dilution after procurement.
Allogeneic umbilical cord blood plasma combined with mononuclear cells. Minimally manipulated.
Both product lines are characterized using human cytokine array analysis (RayBiotech AAH-CYT-5-8), mass spectrometry proteomics, and mixed lymphocyte reaction (MLR) assays. Donor screening follows FDA 21 CFR 1271. Sterility and endotoxin testing performed by VRL Eurofins per USP <71> and USP <85>.
// FACILITY
// DOCUMENTATION
An independent COA from Eurofins — not an in-house report. Covers sterility (USP <71>), endotoxin (USP <85>), and identity.
Describes the current batch in detail: exosome count, growth factor panel, particle size, source, and processing parameters.
Documentation is tied to the specific batch you receive. Every vial traces back to a screened donor and a documented manufacturing run.
Full-term, live-birth donated tissue. Donor qualification per FDA 21 CFR 1271, including infectious disease testing (HIV, HBV, HCV, CMV, HTLV, syphilis, West Nile, Zika, SARS-CoV-2).
We don't ask you to trust us. We hand you the documentation and let you decide.
If a competitor can't produce an independent COA, batch traceability, and donor screening records for the exact batch they're shipping you — ask why.
Request current-batch documentation →// HOW TO EVALUATE
Tell us your name, professional role, and what you're evaluating. We send the documentation — not a pitch deck.
Exosome count, growth factor panel, sterility, endotoxin, donor screening. Take it to your team. Compare it to what you're using now.
If the material meets your standards, we'll discuss current inventory and logistics. If it doesn't, we'd rather you know that before you buy.
// SCOPE
We do: Supply MSC exosome material. Provide independent documentation. Maintain batch traceability. Answer technical questions about specifications, sourcing, and inventory.
We don't: Provide medical, clinical, or legal advice. Advise on use, protocols, or outcomes. Make therapeutic, disease, efficacy, safety, dosing, or FDA-approval claims. Sell to patients.
Decisions about how research material is used rest entirely with the qualified professionals who order it. Practices rely on their own regulatory counsel.
Request the current-batch Eurofins COA and specification sheet.
Request documentation →